251 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)
Pill with imprint 251 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.375 mg. It is supplied by Par Pharmaceutical Inc.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 251
Pramipexole Dihydrochloride Extended-Release
- Imprint
- 251
- Strength
- 0.375 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc
- National Drug Code (NDC)
- 10370-0251
Related Images for "251"
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 195 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
- Other brands
- Mirapex, Mirapex ER
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.